$1.82
+0.16 (+9.31%)
Analyst Consensus
Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+603.8% upside
Low Target
$8.62
Average Target
$12.81
High Target
$14.59
Current Price
$1.82
Current
$1.82
$1.82
Target
$12.81
$12.81
$8.62
$12.81 avg
$14.59
Scenario Analysis
Bear Case
$8.62
373.6%
Low target
Base Case
$12.81
+603.8%
Avg target
Bull Case
$14.59
+701.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$12.45
-85.4% from high
52-Week Low
$9.35
+-80.5% from low
Target vs 52W High
$12.81
+2.9% vs high
Next Earnings Report
Feb 19, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.26
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |